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Little is known about the gene regulatory networks
(GRNs) distinguishing extraembryonic endoderm
(ExEn) stem (XEN) cells from those that maintain
the extensively characterized embryonic stem cell
(ESC). An intriguing network candidate is Sox17, an
essential transcription factor for XEN derivation and
self-renewal. Here, we show that forced Sox17
expression drives ESCs toward ExEn, generating
XEN cells that contribute to ExEn when placed
back into early mouse embryos. Transient Sox17
expression is sufficient to drive this fate change
during which time cells transit through distinct inter-
mediate states prior to the generation of functional
XEN-like cells. To orchestrate this conversion pro-
cess, Sox17 acts in autoregulatory and feedforward
network motifs, regulating dynamic GRNs directing
cell fate. Sox17-mediated XEN conversion helps
to explain the regulation of cell-fate changes and
reveals GRNs regulating lineage decisions in the
mouse embryo.
INTRODUCTION
The mammalian preimplantation embryo consists of three
distinct lineages, the epiblast (EPI), which forms the embryo
proper, and two extraembryonic tissues, the trophectoderm
and the primitive endoderm (PE). The trophectoderm is the first
lineage specified by embryonic day (E) 3.5 when it segregates
from the inner cell mass (ICM). As development proceeds, the
trophectoderm contributes to the trophoblast layers of the
placenta. ICM cells initially coexpress markers characteristic of
both PE and EPI but showmutually exclusive PE- or EPI-specific
expression in a ‘‘salt-and-pepper’’ distribution by E3.5. Spatial780 Cell Reports 9, 780–793, October 23, 2014 ª2014 The Authorssegregation of the PE and preimplantation EPI lineages occurs
by E4.5 (Chazaud et al., 2006; Gardner and Rossant, 1979; Plusa
et al., 2008). Although the preimplantation EPI goes on to form all
fetal tissues after implantation, the PE principally forms ExEn
tissues of the yolk sac that surround and pattern the embryo,
collectively described as the ExEn.
Specification of the trophectoderm, PE, and preimplantation
EPI represents the first cell-fate changes that occur during
embryonic development. Lineage-specific transcription factors
driving these cell-fate changes have been identified by gene
expression and functional analysis in embryos, but elucidating
the GRNs in which these transcription factors act is challenging
due to limited cell numbers in the early embryo. The derivation of
three stem cell lines from the preimplantation embryo, tropho-
blast stem cells (Tanaka et al., 1998), XEN cells (Kunath et al.,
2005), and ESCs (Evans and Kaufman, 1981; Martin, 1981) iso-
lated from the trophectoderm, PE, and preimplantation EPI,
respectively, provides powerful tools to study the GRNs direct-
ing early embryonic cell-fate decisions.
The vast majority of work characterizing GRNs maintaining
these stem cell lines has focused on the regulation of ESC self-
renewal and differentiation. ESCs rely on a core GRN regulating
self-renewal and differentiation, made up of Oct4 (Morrison and
Brickman, 2006; Nichols et al., 1998), Nanog (Chambers et al.,
2003; Mitsui et al., 2003), and Sox2 (Masui et al., 2007). This
core GRN is regulated in a feedforward manner by an extended
pluripotency network (Walker et al., 2010). In addition, some
ESC self-renewal factors regulate differentiation toward specific
lineages (Loh and Lim, 2011), including ExEn. Prdm14 protects
ESCs fromacquiring ExEn fate by directly repressing ExEn genes
and simultaneously activating ESC genes (Ma et al., 2011). Simi-
larly, Tbx3 maintains ESC self-renewal, whereas loss of Tbx3 in
ESCs induces ExEn differentiation (Ivanova et al., 2006; Lu
et al., 2011; Niwa et al., 2009). Sall4, on the other hand, has
dual positive roles in ESC and XEN cell fate. In ESCs, Sall4 acts
in an interconnected GRN with Oct4, Sox2, and Nanog (Sakaki-
Yumoto et al., 2006; Wu et al., 2006; Zhang et al., 2006). In XEN
cells, Sall4 directly regulates XEN genes and loss of Sall4 in XEN
cells is incompatible with XEN self-renewal (Lim et al., 2008).
Although some overlap in the nodes of ESC and XEN cell
GRNs have been identified, GRNs distinguishing XEN cells
from those characterized in ESCs are not well understood.
When overexpressed in ESCs, the PE-specific genes Gata6
and Gata4 drive XEN cell commitment, and the loss of these
genes in XEN cells is incompatible with self-renewal (Fujikura
et al., 2002; Lim et al., 2008; Shimosato et al., 2007). SOX tran-
scription factors have also been implicated in maintaining XEN
cell identity. Loss of either Sox7 or Sox17 disrupts XEN cell
self-renewal (Lim et al., 2008). Although Sox17/ mutants
generate PE, XEN cell lines cannot be derived from these em-
bryos (Artus et al., 2011; Kanai-Azuma et al., 2002; Niakan
et al., 2010). Overexpression studies using SOX transcription
factors have produced disparate results. SOX7 overexpression
in human ESCs activates ExEn genes (Se´guin et al., 2008),
whereas Sox7 overexpression in mouse ESCs has little effect
on ExEn gene expression (Futaki et al., 2004).Sox17 overexpres-
sion has been reported to induce both ExEn and definitive endo-
derm genes during mouse embryoid body differentiation (Qu
et al., 2008; Shimoda et al., 2007). However, Sox17 overexpres-
sion in mouse ESCs failed to prevent differentiation of all three
germ layers in teratoma assays (Niakan et al., 2010). Intriguingly,
Sox17+ cells isolated from mouse ESC cultures are committed
to XEN cell fate, contributing to the ExEn region of chimeric
mouse embryos (Niakan et al., 2010). In contrast, we have previ-
ously shown thatSOX17 overexpression in human ESCs induces
mesendoderm fate (Se´guin et al., 2008).
In this study, we aimed to resolve the role of Sox17 in the XEN
cell GRN. By overexpressing Sox17 in mouse ESCs, we have es-
tablished stable, transgene-independent XEN-like (Sox17-XEN)
cells that contribute to ExEn in vivo, highlighting the ability of
Sox17 to drive cell-fate changes. We further show that Sox17
is a potent inducer of XEN cell fate, only requiring transient over-
expression to initiate the XEN GRN. Using RNA sequencing
(RNA-seq) time course analyses in combination with genome-
wide transcription factor binding data, we developed a dynamic
regulatory model of the GRNs involved in XEN cell specification
and identified putative regulators of XEN cell identity. As pre-
dicted by our model, we confirmed that Nr5a2 negatively regu-
lates XEN cell genes, thereby repressing ExEn differentiation in
ESCs. Together, our findings confirm Sox17 as a key node in
the ExEn GRN and that Sox17-mediated XEN conversion is a
useful model to elucidate GRNs directing early mammalian
cell-fate decisions.
RESULTS
Establishment of Functional XEN-like Cells from ESCs
by Sox17 Overexpression
To test the ability of Sox17 to drive XEN cell fate in mouse ESCs,
we used doxycycline (dox)-inducible Sox17-ESCs (Rugg-Gunn
et al., 2012) to activate the expression of Sox17 and eGFP.
Following induction, Sox17 was significantly activated in
Sox17-ESCs while remaining in physiological range, at levels
less than 20% of Sox17 expression in embryo-derived XEN cells
(Figure S1). Upon dox treatment, ExEn genes (Col4a1, Col4a2,CLama1, Sox7, Gata4, and Gata6) were induced within 24 hr
and Collagen IV, Laminin, and Gata4 proteins were expressed
within 48 hr (Figures S2A–S2C). Extended culture of two
Sox17-ESC clones in dox under ESC self-renewal conditions
(serum and LIF) promoted morphological changes resulting in
dispersed cells, demonstrating flat morphology around the
periphery of ESC colonies by day 6 (Figure 1A). By day 12, a
homogenous population of small, round, refractile cells, indistin-
guishable from embryo-derived XEN cells, was established
(Figure 1A).
Following Sox17 activation, expression of ExEn genes
continued to increase, stabilizing at levels equivalent to XEN
cells by day 12 (Figure 1B). Concomitantly, the expression of
ESC genes Oct4 and Nanog was reduced (Figure 1C). Definitive
endoderm (Gsc and Cxcr4), mesoderm (T and Tbx6), and ecto-
derm (Sox1 and Pax6) genes were not significantly induced, sug-
gesting that Sox17 drives differentiation toward ExEn (Figures
1D–1F).
To determinewhether the XEN cell-like phenotype acquired by
ESCs in response to Sox17 overexpression is stable in the
absence of transgene expression, we cultured Sox17-XEN cells
without dox for at least 30 days. Sox17-XEN cells maintained
expression of XEN proteins Collagen IV, Laminin, Gata4,
Gata6, and Sall4 (Figures 1G and 1H), whereas ESC transcription
factors Oct4 and Nanog were not detected (Figure 1H). Sox17-
XEN cells maintained a XEN cell-surface profile (Rugg-Gunn
et al., 2012), expressing CD140a, Robo2, and CD26 while lack-
ing expression of ESC markers CD81, CD31 (Figures 1I and 1J),
and definitive endoderm maker CD184 (Figure 1J). Sox17-XEN
cells maintained a XEN-like phenotype for greater than 90 days
in the absence of dox.
When placed back into the embryo, XEN cells contribute to the
parietal endoderm layer of mouse postimplantation embryos
(Kunath et al., 2005). Based on the similarity of Sox17-XEN cells
to embryo-derived XEN cells, we hypothesized that Sox17-XEN
cells would function as ExEn in vivo. To test this, Sox17-XEN
cells ubiquitously expressing mCherry were injected into wild-
type host blastocysts and analyzed for embryonic contribution
at E6.5, E7.5, and E8.5. All chimeric embryos observed con-
tained Sox17-XEN cells exclusively in the parietal endoderm
(Figures 1K and 1L).
Taken together, these findings support a model in which
Sox17 is a key ExEn lineage-determining transcription factor.
Upon overexpression in ESCs, Sox17 directs XEN gene activa-
tion and pluripotency repression, thereby driving bona fide
XEN cell commitment, as determined by chimera formation
assays.
Transient Expression of Sox17 Is Sufficient to Drive XEN
Cell Fate in ESCs
The ability of Sox17-XEN cells to maintain a stable phenotype in-
dependent of transgene expression suggests that a transition
from exogenous transgene control to endogenous control of
cell fate occurs during XEN conversion. To determine transgene
kinetics during this process, we evaluated GFP expression using
flow cytometry and found that transgene silencing began before
day 6 of dox culture (Figure 2A; Figure S3A). Next, day 6 cells
were sorted (Figure 2B; Figure S3B), and gene expression ofell Reports 9, 780–793, October 23, 2014 ª2014 The Authors 781
Figure 1. Sox17 Overexpression in ESCs Induces Functional XEN-like Cells
(A) Photomicrographs of Sox17-ESCs (clone 4J) cultured in dox. Scale bar, 200 mm.
(B–F) Gene expression during Sox17-ESC dox culture. Two independent clones (3F [pink] and 4J [blue]) are shown at indicated time points relative to uninduced
Sox17-ESCs alongside embryo-derived XEN cells (red triangle) or embryoid bodies (EBs) (orange circles). Error bars = SEM of three independent experiments.
ND, not detected.
(G and H) Immunostaining of Sox17-ESCs and transgene-independent Sox17-XEN cells (clone 4J). Scale bar, 45 mm.
(I and J) Flow cytometric analysis of Sox17-XEN cells (clone 4J) compared to Sox17-ESCs and EB-derived definitive endoderm cells.
(K) E8.5 Sox17-XEN chimeric embryo. Scale bar, 225 mm.
(L) Rate of chimerism detected in recovered embryos following blastocyst injection.
See also Figures S1 and S2.
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GFP+ (4J = 76.3% and 3F = 82.8%) and GFP (4J = 23.7% and
3F = 17.2%) cells was evaluated. Oct4 and Nanog expression
was comparable between GFP+ and GFP day 6 cells (Fig-
ure 2C), but GFP+ cells expressed significantly higher levels
of XEN genes (Gata4, Gata6, Sox7, Col4a1, Col4a2, and
Lama1) (Figure 2D). When GFP+ and GFP day 6 cells were
cultured for an additional 12 days in dox, both cell populations
acquired comparable XEN-like cell-surface profiles (Figure 2E;
Figure S3C).
These results suggested that transient Sox17 overexpression
might be sufficient to induce XEN cell fate in ESCs. To test this,
we removed dox from cultures after 12, 24, 36, 48, and 72 hr of
treatment and subsequently tracked these cells by flow cytom-
etry at days 6, 12, and 20 (Figure 2F; Figure S3D). We found
that a 12 hr pulse of Sox17 overexpression induced CD26
expression in a subset of cells by day 12, whereas 48 hr of
transgene overexpression induced XEN marker expression
changes with equivalent kinetics to cells continuously cultured
in dox (Figure 2F; Figure S3D). Sox17-XEN cells derived
following 48 hr of transgene overexpression (Sox17(48)-XEN
cells) combined with an additional 30 days of culture maintain
a cell-surface profile indistinguishable from previously estab-
lished Sox17-XEN cells (Figures 2G and 2H; Figures S3E
and S3F).
To determine whether Sox17(48)-XEN cells were functionally
equivalent to Sox17-XEN cells, we performed chimera assays
and found that Sox17(48)-XEN cells also contributed exclusively
to the parietal endoderm of chimeric embryos (Figures 2I and 2J).
Taken together, these findings show that transient Sox17 over-
expression is sufficient to engage the XENGRN in ESCs, thereby
restricting cell fate to ExEn.
Sox17-Mediated XEN Conversion Is Highly Efficient
To determine the efficiency of Sox17-XEN establishment, we
followed conversion of individual ESCs. As others have in the
field, we defined conversion efficiency as the potential of a
single cell to give rise to reprogrammed daughter cells (Hanna
et al., 2009). CD31+CD140a cells sorted from two independent
Sox17-ESC clones or wild-type ESCs were individually depos-
ited into 96-well plates and subsequently cultured in dox (Fig-
ure 3A). XEN cell morphology could be detected by day 14 in
greater than 75% of clones derived from either starting Sox17-
ESC line (n = 48 clones [3F] and n = 53 clones [4J]) (Figure 3B).
By day 70, greater than 90% of Sox17-ESC clones gave rise to
daughter cells with XEN-like morphology (Figure 3B). No XEN-
like cells were ever detected in wild-type ESC clones (n = 64
clones) (Figure 3B).
To quantify XEN conversion, expression of CD140a and CD31
were measured at day 70. A detection value of >2% CD140a+
was used as the minimal threshold for XEN cell conversion in
clonal populations, whereas >2% CD31+ cells was used as the
minimal threshold for defining the presence of ESCs. One hun-
dred percent of Sox17-ESC clones gave rise to CD140a+
daughter cells (Figures 3C and 3D), whereas less than 18% of
Sox17-ESC clones contained a subset of CD31+ cells (Figures
3E and 3F). These results demonstrate that most if not all
ESCs have the ability to acquire XEN fate following Sox17 over-
expression, albeit at different latencies.CCells Transit through Distinct Compartments during
Sox17-Mediated XEN Conversion
We previously observed a subset of Sox17-ESCs negative for
both XEN and ESC surface markers when cultured in dox for
6 days (Figure 2F), suggesting that cells may transit through a
double-negative compartment during XEN conversion. To test
this, we sorted cells at day 6 using CD140a and CD31 (Figure 4A;
FigureS4A) andanalyzedgeneexpression of eachcompartment.
Cells located in the XEN compartment (CD140a+CD31) had
significantly higher expression of XEN genes (Col4a1, Col4a2,
Lama1, Gata6, Gata4, and Sox7) compared to CD140aCD31
cells and CD140aCD31+ cells (Figure 4B; Figure S4B). Nanog
expression was significantly reduced in CD140a+CD31 cells
compared to CD140aCD31+ cells; however, no significant dif-
ferences were observed for Oct4 and Sall4 expression between
compartments (Figure 4B). After continued culture, a subset of
cells from day 6 CD140aCD31 and CD140aCD31+ compart-
ments activated CD140a expression (Figure 4C; Figure S4C),
demonstrating that cells undergoing XEN conversion transit
through a distinct compartment, characterized by the lack of
both ESC marker CD31 and XEN cell marker CD140a.
Sox17-D6 Cells Are Distinct from Sox17-XEN Cells
To determine whether XEN-like cells present by day 6 of Sox17
overexpression (Sox17-D6) (Figure 4A) were equivalent to
stable XEN-like cells, we performed RNA-seq to compare the
expression profiles of Sox17-D6 and Sox17-XEN cells (day 60).
Hierarchical clustering demonstrated that Sox17-D6 cells are
distinct from Sox17-XEN and embryo-derived XEN cells, sug-
gesting that these cells may represent an intermediate state
of XEN conversion (Figure 4D). Although similar to embryo-
derived XEN cells, stable Sox17-XEN gene expression is
distinct, despite their ability to contribute to the parietal endo-
derm in vivo.
To identify gene expression patterns across cell states, we
performed K-means clustering, identifying four distinct clusters
(Figure 4E; Table S1). We compiled a list of statistically enriched
pathways and gene ontology (GO) terms for each cluster (Table
S2) and created enrichment maps (Merico et al., 2010) (Fig-
ure 4F). Fast-response downregulated genes were associated
with neural processes, trophoblast development, and FGF
signaling. Slow-response downregulated genes were associ-
ated with mesoderm and neural development, cell adhesion,
and Wnt signaling. Upregulated genes were associated with
cell motility, endoderm development, and BMP signaling, a
pathway involved in ExEn development (Coucouvanis and Mar-
tin, 1999). These results suggest that ectopic Sox17 expression
drives waves of gene activation and repression regulating the
acquisition of ExEn fate.
Interestingly, a cluster of genes uniquely expressed in Sox17-
D6 cells (Figure 4E) associated with intestinal functions such as
regulation of intestinal cholesterol absorption was also identified
(Figure 4F; Table S2). Given that a subset of the ExEn, the
visceral endoderm (VE), performs intestinal-like functions prior
to placental development (Jollie, 1990), we postulated that
Sox17-D6 cells may be more similar to VE than parietal endo-
derm, the ExEn tissue that XEN cells resemble most (Artus
et al., 2012; Kunath et al., 2005; Paca et al., 2012). To this end,ell Reports 9, 780–793, October 23, 2014 ª2014 The Authors 783
(legend on next page)
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Figure 3. Sox17-Mediated XEN Conversion
Is Highly Efficient
(A) Single-cell Sox17-mediated XEN conversion
experimental outline.
(B) Cumulative percentage of Sox17-ESC and wild-
type ESC clones exhibiting XEN cell morphology at
indicated time points.
(C) Flow cytometric measurement of CD140a
expression inSox17-ESCandwild-typeESCclones.
(D) Binned data from (C).
(E) Flow cytometric measurement of CD31 expres-
sion in Sox17-ESC and wild-type ESC clones.
(F) Binned data from (E).we askedwhether VE geneswere uniquely enriched in Sox17-D6
cells using Gene Set Enrichment Analysis (GSEA) (Subramanian
et al., 2005) and a VE gene set we constructed using published
microarray data (Figure S5; Table S3) (Paca et al., 2012). The
VE gene set was significantly enriched in Sox17-D6 cells, sug-
gesting that Sox17-D6 cells are more similar to VE than Sox17-
XEN cells (Figure 4G). Moreover, Sox17-D6 cells express VE
genes Amn, Cubn, and Lrp2 and express high levels of E-cad-
herin while expressing low levels of parietal endoderm genes
Krt23, Nid1, and Krt18 (Figures 4H and 4I). These analyses
demonstrate that Sox17 directs ESCs to undergo a stepwise
XEN fate conversion during which cells transit through interme-
diate states, including a transient VE-like state.
Generation of a Dynamic Regulatory Map of Sox17-
Mediated XEN Conversion
To further understand Sox17-activated gene expression
changes during XEN conversion, we performed an RNA-seq
time series. Given that cell-surface protein expression does not
change within the first 48 hr of dox treatment (Figures S6A and
S6B), we performed RNA-seq on unsorted cells after 0, 7, 21,
35, and 49 hr of dox culture. These data were inputted into the
Dynamic Regulatory Events Miner (DREM) algorithm (Ernst
et al., 2007), plotting dynamic gene expression throughout
XEN conversion (Figure 5A). Each path (line) represents a group
of genes sharing similar expression, and points at which expres-Figure 2. Transient Sox17 Expression Is Sufficient to Drive XEN Conversion in ESCs
(A) Flow cytometric analysis of GFP expression in Sox17-ESCs (clone 4J) cultured in dox compared to unin
(B) FACS plot of Sox17-ESCs (clone 4J) on day 6 of dox culture.
(C and D) Expression of pluripotency genes (C) and XEN genes (D) in sorted cells (B) relative to uninduced S
cells. Error bars = SEM of six experiments (two clones 3 three independent experiments).
(E) Flow cytometric analysis of sorted Sox17-ESCs (B) at day 18 of dox culture.
(F) Sox17-ESCs (clone 4J) were treated with dox transiently for 12, 24, 36, 48, or 72 hr and tracked at indic
(G and H) Flow cytometric analysis of Sox17(48)-XEN cells (clone 4J) compared to Sox17-ESCs and EB-de
(I) E8.5 Sox17(48)-XEN chimeric embryo. Scale bar, 225 mm.
(J) Rate of chimerism detected in recovered embryos following blastocyst injection.
See also Figure S3.
Cell Reports 9, 780–793sion diverges among a group of genes,
known as bifurcation points, are indicated
in green. Paths containing known ESC and
XEN genes are outlined in Figure 5B.
The identification of gene activation
and repression waves using this algo-rithm further supports a model of a Sox17-activated multi-
phasic XEN conversion process. Next, we performed pathway
and GO term enrichment analyses on gene groups contained
in particular expression paths outlined by our dynamic regula-
tory map. The earliest activated genes (path 4) were induced
after 7 hr and are associated with developmental processes
including endoderm development and retinoic acid signaling
(Figures 5A, 5C, and 5D), a signaling molecule used to induce
XEN fate in ESCs (Cho et al., 2012). A subset of path 4 endo-
derm, BMP, and retinoic acid signaling pathway genes main-
tained high expression throughout XEN establishment (path
13) (Figures 5A, 5C, and 5D). By 21 hr, repression of genes
associated with ectoderm and mesoderm development began
(path 21) (Figures 5A, 5C, and 5D).
After 49 hr, secondary waves of gene regulation were initiated,
including activation of genes associated with cell movement
(path 24). Genes associated with cellular processes such as
ion transport as well as additional developmental processes
including lung development, which utilizes XEN genes including
Tbx3 andGata6, were also upregulated during this time (path 34)
(Figures 5A, 5C, and 5D). Simultaneously, secondary waves of
gene repression began after 49 hr, suppressing genes associ-
ated with mesoderm, ectoderm, and cell adhesion (path 33)
(Figures 5A, 5C, and 5D).
Together, these data support a multiphasic model of ExEn fate
acquisition during which ExEn gene activation is followed byduced Sox17-ESCs.
ox17-ESCs and compared to embryo-derived XEN
ated times using flow cytometry.
rived definitive endoderm (DE).
, October 23, 2014 ª2014 The Authors 785
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subsequent repression of ectodermal and mesodermal gene
repression.
Prediction and Testing of GRN Motifs Regulating XEN
Cell Fate
Next, we combined genome-wide transcription factor binding
data for known ESC and XEN cell GRN members (Table S4)
with transcription factor binding data included in DREM and
used this algorithm to annotate DREM gene expression paths
(outlined in Figure 5A) with transcription factors predicted by
DREM to regulate the expression of genes contained in a partic-
ular path. Interestingly, Sall4 was predicted to regulate several
bifurcation points in combination with Sox17 (Figure 6A). Both
transcription factors are predicted to regulate early XEN genes
expressed highly by 21 hr (path 13), as well as XEN genes acti-
vated by 49 hr after Sox17 overexpression (path 29). Although
Gata4 and Gata6 are established XEN cell-fate regulators (Fuji-
kura et al., 2002; Lim et al., 2008; Shimosato et al., 2007), their
transcriptional targets have not been identified in XEN cells.
Our analysis predicts that Gata4 and Gata6 act as both activa-
tors (paths 10, 24, and 34) and repressors (path 16) during XEN
establishment (Figure 6A).
In addition to predicting roles for XEN GRN members, our
analysis also predicted regulators not previously associated
with XEN cell fate including Foxa2, Foxo1, Pou2f1, Hnf4a,
Foxd3, and Nr5a2 (Figure 6A). To determine whether putative
XEN transcription factors are actually active in XEN cells, we re-
analyzed our time-series expression data and determined those
transcription factors expressed uniquely in either XEN cells or
ESCs or expressed in both cell types (Figure 6B). We then cate-
gorized putative XEN regulators into three network motifs: (1)
XEN repressors expressed in ESCs, (2) XEN activators ex-
pressed in XEN cells, and (3) transcription factors expressed in
both ESCs and XEN cells, in which these factors play unique
roles in each cell type (Figure 6C).
An intriguing XEN repressor candidate is Nr5a2. Nr5a2 has
been used to replace Oct4 during induced pluripotent stem
cell (iPSC) reprogramming, and chromatin immunoprecipitation
sequencing (ChIP-seq) results demonstrate that Nr5a2 is bound
to regions regulating numerous XEN genes including Hnf4a,
Col4a1, and Lama5 (Heng et al., 2010). We drafted a GRN motif
in which Nr5a2 directly represses XEN genes in ESCs (Figure 7A)
and hypothesized that the loss of Nr5a2 in ESCs should activate
XEN genes in a similar manner to the known XEN repressor
Prdm14 (Ma et al., 2011). To test our hypothesis, we knocked
down Nr5a2 and Prdm14 using small interfering RNA (siRNA)Figure 4. Sox17-XEN Cells Transit through Distinct Phases during Sox
(A) FACS plot of Sox17-ESCs on day 6 of dox culture (clone 4J).
(B) Gene expression analysis of each FACS compartment shown in (A). Error ba
(C) Flow cytometric analysis of cells sorted in (A) at day 12 and 18 of dox culture
(D) Hierarchical clustering of RNA-seq data.
(E) Gene clusters identified by K-means clustering analysis.
(F) Enrichment maps outlining significantly enriched pathways and GO terms for
(G) GSEA comparing the enrichment of a VE gene set (Figure S4) in Sox17-D6 c
(NOM) p values are included.
(H) RNA-seq expression (FPKM values) of VE genes (Amn, Cubn, and Lrp2) and
(I) E-cadherin expression measured by flow cytometry.
See also Figures S4 and S5 and Tables S1, S2, and S3.
C(Figures 7B and 7C) and found that even incomplete knockdown
of Nr5a2 triggered activation of XEN genes after 48 hr, compara-
ble to the effect of Prdm14 (Figure 7D). We integrated this Nr5a2
repression motif into the existing core ESC GRN (Walker and
Stanford, 2009) along with Klf4, Tbx3, and Prdm14 DNA interac-
tions (Table S4), demonstrating that Nr5a2 regulates both self-
renewal and differentiation in ESCs (Figure 7E).
To refine our model of XEN conversion, we integrated gene
expression and transcription factor-DNA interaction data, draft-
ing two distinct GRNs regulating the establishment and mainte-
nance of XEN fate. We predicted that Sox17 would directly
activate XEN transcription factors within 48 hr of overexpression
while ESC GRN members are still expressed, resulting in an in-
termediate state in which members of both ESC and XEN
GRNs are active (Figure 7F). Upon Sox17-XEN establishment,
ESC regulators Nanog, Oct4, Sox2, Nr5a2, Foxd3, and Prdm14
are no longer expressed (Figure 1C; Figure S7), suggesting
that the ESC GRN is inactive in XEN cells. Based on our model,
we predicted that Sox17 maintains its regulation of XEN tran-
scription factors as well its own promoter in a stable XEN state
(Figure 7G).
To test our predicted Sox17 GRN motifs, we performed ChIP-
qPCR to assess Sox17 binding of XEN genes (Niakan et al.,
2010) and found that Sox17 directly activates XEN GRN mem-
bers Sox17, Gata4, Gata6, and Sall4 within 48 hr of Sox17
overexpression and that these interactions are maintained in
Sox17-XEN cells (Figure 7H), confirming that Sox17 acts in
both autoregulatory and feedforward motifs (Figures 7I and 7J)
across cell states suggesting that Sox17 activates dynamic
GRNs to orchestrate XEN cell fate in ESCs.
DISCUSSION
Here, we have shown that Sox17 overexpression in mouse ESCs
efficiently drives cell fate to ExEn, highlighting the central role of
Sox17 in the XEN GRN. Sox17-XEN cells maintain a XEN-like
molecular profile and mimic the ability of XEN cells to contribute
to ExEn in vivo. Although Sox17-induced ExEn gene activation in
mouse ESCs has been previously reported (Niakan et al., 2010),
the affinity tagged Sox17 expression construct used in that study
was heterogeneously activated and did not bind to its own pro-
moter or those regulating XEN GRN members Gata4 and Gata6
(Niakan et al., 2010). Hence, this suggests that, if Sox17 is not
sufficiently expressed or is functionally impaired, Sox17 cannot
adequately activate the XEN GRN and drive ESC conversion to
XEN cells.17-Mediated XEN Conversion
rs = SEM of four independent experiments.
.
gene clusters outlined in (E).
ells versus Sox17-XEN cells. Normalized enrichment score (NES) and nominal
parietal endoderm genes (Krt23, Nid1, and Krt18).
ell Reports 9, 780–793, October 23, 2014 ª2014 The Authors 787
(legend on next page)
788 Cell Reports 9, 780–793, October 23, 2014 ª2014 The Authors
Figure 6. Identification of Putative Regulators of ExEn Cell Fate
(A) Dynamic regulatory map (Figure 5A) annotated with putative regulators of bifurcation points. DREM-identified regulators are listed in red and previously
identified ExEn regulators are listed in black.
(B) FPKM values were plotted for putative XEN regulators in three distinct network motif categories.
(C) XEN repressors expressed in ESCs, XEN activators expressed in XEN cells, and transcription factors expressed in both ESC and XEN cells.
See also Table S4.Ourmouse results also contrast with our prior study performed
using human ESCs, in which SOX17 overexpression directed
mesendoderm specification (Se´guin et al., 2008). This discrep-
ancy is likely due to differences in developmental state between
human and mouse ESCs, as human ESCs have been shown to
be more similar to murine postimplantation epiblast stem cells
(Brons et al., 2007; Tesar et al., 2007). Sox17 also plays a critical
role in early blood development (He et al., 2011; Kim et al., 2007),
suggesting that Sox17 may act within unique GRN modules
specifying distinct tissues, depending on developmental
context.
Although embryo-derived XEN cells provide a model of ExEn
maintenance and differentiation, Sox17-mediated XEN conver-
sion provides a unique tool to explore ExEn specification. Using
this model, we found that ESCs transit through distinct states
characterized by rapid activation of ExEn genes and suppression
of ectodermal genes followed by repression of mesodermal
and ESC genes, which results in an intermediate VE-like state.
Upon continued culture, Sox17-XEN cells acquire a parietal
endoderm-like phenotype similar to embryo-derived XEN cells
(Kunath et al., 2005). Interestingly, BMP signaling directs XEN
differentiation to VE-like cells (Artus et al., 2012; Paca et al.,
2012), suggesting that BMP signaling-associated genes active
during XEN conversion may drive an intermediate VE-like state.
We combined our dynamic model of ExEn specification with
transcription factor-DNA interaction data, which allowed us toFigure 5. Construction of a Dynamic Regulatory Map for Sox17-Media
(A) DREM-generated dynamic regulatory map during Sox17-ESC (clone 4J) dox c
paths of interest are labeled by path number.
(B) DREM paths containing known ESC and XEN cell markers.
(C and D) Enrichment maps outlining significantly enriched pathways and GO te
See also Figure S6.
Cpredict regulators of XEN specification that can be classified
into three categories: XEN repressors active in ESCs, XEN acti-
vators in XEN cells, and transcription factors expressed in both
ESCs and XEN cells, playing a unique role in each cell type. Us-
ing this model, we predicted and tested a role for the ESC self-
renewal factor Nr5a2 (Gu et al., 2005; Heng et al., 2010) in the
regulation of XEN fate, demonstrating the ability of Nr5a2 to
repress XEN genes in ESCs. Embryo studies support a role for
Nr5a2 in endoderm regulation as Nr5a2 regulates the expression
of ExEn-associated genes in definitive endoderm lineages (Pare
et al., 2001; Rausa et al., 1999), and its expression is required in
the ExEn for proper patterning of the embryo (Labelle-Dumais
et al., 2006).
The current model suggests that PE is specified when recip-
rocal inhibition of Nanog and Gata6 is disrupted in favor of
Gata6 (Lanner, 2014). In vitro, overexpression of Gata6 or
Gata4 drives XEN fate (Fujikura et al., 2002); however, only
Gata6 is required for PE specification in vivo (Schrode et al.,
2014). Here, we show that Sox17 directly activates Gata6 and
Gata4 when overexpressed in ESCs, allowing Sox17 to drive
XEN conversion. Others have shown that Sox17 is not required
for Gata6 expression during ExEn differentiation but is required
for normal Gata4 expression (Niakan et al., 2010). These data
suggest that Sox17 GRN motifs reinforce PE fate, placing
Sox17 downstream of Gata6 in the ExEn GRN. However, loss-
of-function studies suggest that Sox17 is a critical member ofted XEN Conversion
ulture. Expression levels relative to uninduced Sox17-ESCs. Gene expression
rms for indicated gene expression paths (A).
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Figure 7. Sox17 Regulates Dynamic Networks Driving XEN Cell Fate
(A) Predicted Nr5a2 repressive motif in ESCs.
(B) Nr5a2 expression 48 hr after Nr5a2 knockdown in wild-type ESCs.
(C) Prdm14 expression 48 hr after Prdm14 knockdown in wild-type ESCs.
(D) Expression of XEN genes in wild-type ESCs 48 hr after knockdown of Nr5a2 or Prdm14. Error bars = SEM of two independent experiments.
(E–G) Schematic of GRN interactions regulating ESC and XEN cell states. Active interactions in Sox17-ESCs are shown in color. Inactive modules are shown in
gray (E). (F) Active interactions in Sox17-ESCs after 48 hr of Sox17 overexpression are shown in color. Inactive modules are shown in gray. (G) Active interactions
in Sox17-XEN cells are shown in color. Inactive modules are shown in gray.
(legend continued on next page)
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the XEN GRN because XEN cells cannot be derived from
Sox17/ embryos (Niakan et al., 2010) and knockdown of
Sox17 disrupts XEN self-renewal (Lim et al., 2008).
Transient Sox17 overexpression drives highly efficient XEN
conversion in ESCs, suggesting that the GRNs governing XEN
and ESC fates are closely connected, allowing for quick activa-
tion or repression of the opposing lineage. In our model, Sox17
overexpression activates XEN genes within 7 hr, followed by
repression of ESC genes beginning within 21 hr. Sox17 directs
these gene expression changes using at least two distinct mech-
anisms. Within 48 hr, Sox17 activates a positive autoregulatory
loop, which allows Sox17 to increase the rate of its own tran-
scription upon reaching an activation threshold. Such positive
autoregulatory loops generate cell-cell variability (Walker and
Stanford, 2009), which could explain the variable latencies
observed across clones during Sox17-mediated XEN conver-
sion. Second, Sox17 activates positive feedforward loops in
which it directly activates downstream XEN genes while simulta-
neously activating XEN GRN members. We analyzed Sox17
binding in XEN cells (Niakan et al., 2010) and found that Sox17
directly repressesNr5a2, suggesting a third mechanism in which
Sox17 may prevent the action of XEN repressors. Others have
suggested that Sox17 may compete with the binding of pluripo-
tency transcription factors Nanog and Sox2 at XEN promoters to
regulate ExEn fate (Niakan et al., 2010).
In conclusion, Sox17-mediated XEN conversion provides
insight into how lineage-determining transcription factors drive
cell-fate decisions in embryo-derived stem cells. By integrating
gene regulatory data, we have illustrated a model in which
each stem cell state possesses a GRN that maintains self-
renewal while repressing the self-renewal network of the
opposing stem cell state. When a member of one of these
GRNs is overexpressed, as demonstrated here by Sox17, dy-
namic GRNs orchestrate cell-fate change. Understanding how
GRNs drive cell-fate decisions is essential for the effective gen-
eration of specific cell types for downstream in vitro studies, the
derivation of more mature cell types for regenerative medicine
purposes, or developing novel therapeutics for degenerative
diseases and malignancies.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
R1 ESCs (Nagy et al., 1993) were cultured at 37C and 5% CO2 on mitotically
inactivated mouse embryonic fibroblasts (MEFs) in ESC media containing
Dulbecco’s modified Eagle medium supplemented with 15% fetal bovine
serum (FBS) (HyClone, Lot KSD28666), 2 mM GlutaMAX (Invitrogen),
0.1 mM beta-mercaptoethanol (Sigma-Aldrich), 0.1 mM nonessential amino
acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen), and 1,000 U/ml LIF
(Chemicon). For definitive endoderm differentiation, ESCs were cultured as
embryoid bodies (Kubo et al., 2004) for 2 days after which 100 ng/ml Activin
A (R&D Systems) was added for an additional 2 days.(H) Sox17 occupancy in Sox17-ESCs after 48 hr of dox treatment and in Sox17-XE
IgG-bound chromatin over a negative control region (Ppil4; Niakan et al., 2010) an
SEM of two biological replicates.
(I) Schematic of Sox17 autoregulatory loop active in (F) and (G).
(J) Schematic of Sox17 feedforward loops active in (F) and (G).
See also Figure S7.
CSox17-ESCs (Rugg-Gunn et al., 2012) were cultured in ESC media with
100 ng/ml dox (Sigma) to induce Sox17 expression. Sox17-XEN cells were
maintained in ESCmedia. For chimera experiments, cells were electroporated
with 10 mg of PB-CAG-mCherry and 1 mg pCAG-PBase (Wang et al., 2008)
followed by 150 mg/ml G418 selection (Gibco).
IM8AR XEN cells (Kunath et al., 2005) were cultured in RPMI 1640
(Gibco) supplemented with 15% FBS (HyClone, Lot KSD28666), 1 mM sodium
pyruvate (Gibco), 100 u mM beta-mercaptoethanol (Sigma-Aldrich), and 2 mM
L-glutamine (Gibco) at a ratio of 30% standard media to 70% MEF-condi-
tioned media on 0.1% gelatin-coated plates or MEFs.
For siRNA experiments, ESCs were transfected with siRNA pools (Dharma-
con) against Nr5a2 (L-047044-01) or Prdm14 (L-043221-01) at 50 mM final
concentration using Lipofectamine 2000 (Invitrogen) following the manufac-
turer’s instructions.
Gene Expression Analysis
Real-time PCR gene expression analysis was carried out as previously
described (Se´guin et al., 2008). Primer sequences are included in the Supple-
mental Experimental Procedures.
Illumina Sequencing and Data Analysis
RNA-seq libraries were prepared and sequenced at the McGill University and
GenomeQuebec Innovation Centre using an Illumina HiSeqGenome Analyzer;
100-bp-long reads were obtained. Illumina reads were aligned to the mm9
mouse genome assembly and analyzed using the tuxedo package as previ-
ously described (Trapnell et al., 2012).
Immunostaining
Immunostaining was performed as previously described (Se´guin et al., 2008)
using antibodies listed in the Supplemental Experimental Procedures. Images
were captured using a Zeiss Axiovert 200 inverted microscope with a Hama-
matsu C9100-13 EM-CCD camera and aQuorum spinning disk confocal scan-
ning head. The Volocity software package (PerkinElmer) was used for image
acquisition.
Flow Cytometry
Generation and immunostaining of single-cell suspensions are outlined in
the Supplemental Experimental Procedures. Flow cytometry was per-
formed using a Becton Dickinson LSR II and Dako Cytomation MoFlow
at the SickKids-UHN Flow Cytometry Facility. Fluorescence-activated
cell sorting (FACS) plots were generated using FlowJo software (Tree
Star).
Chimeras
Chimeric embryos were generated as previously described (Kunath et al.,
2005) with stable Sox17-XEN cells or Sox17(48)-XEN cells. In brief, wild-
type blastocysts (C57BL/6J 3 B6D2F1/J) were collected at 3.25 days post-
coitum (dpc) and injected with 10–20 mCherry-labeled cells and transferred
into pseudopregnant surrogates (2.5 dpc). Embryos were dissected at 6.5,
7.5, and 8.5 dpc and were imaged using a MZ16F microscope (Leica) equip-
ped with a MicroPublisher 5.0 RTV camera (Qimaging). All animal experi-
ments were performed in accordance with Canadian Council for Animal
Care guidelines.
Chromatin Immunoprecipitation
Chromatin was formaldehyde crosslinked and sonicated to approximately
1 kb lengths and analyzed using the Magna ChIP assay kit (Millipore,
17-611) according to the manufacturer’s instructions. Chromatin wasNcells. Percentage of input and fold enrichment were calculated for Sox17 and
d presented as relative enrichment over uninduced Sox17-ESCs. Error bars =
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immunoprecipitated using 10 mg of goat anti-Sox17 (R&D, AB-108-C) or anti-
goat immunoglobulin G (IgG) (R&D, AB-108-C). Resulting DNA was used as
input for real-time PCR using previously published primers (Niakan et al.,
2010).
Statistical Analysis
Unpaired t tests were used to compare two groups. Results were expressed as
mean ± SEM. *p < 0.05; **p < 0.01. t tests were performed using Prism5
(GraphPad).
ACCESSION NUMBERS
RNA-seq data of R1 ESCs, IM8AR XEN cells, and Sox17-ESC time course
have been deposited at NCBI Gene Expression Omnibus under the accession
number GSE61102.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.09.026.
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